Thrombocytopenia associated with sodium valproate treatment
Andreas N. Neophytides, John G. Nutt, Jules R. Lodish
Abstract
Andreas N. Neophytides, John G. Nutt, Jules R. Lodish
Abstract
The administration of sodium valproate to 30 patients in daily doses of 1,200 to 3,000 mg was associated with a significant reduction of the platelet count. Thrombocytopenia without any concomitant bleeding abnormalities occurred in 10 of the patients. Platelet counts returned to baseline levels after withdrawal of the drug.
OpenAlex reports 71 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The administration of sodium valproate to 30 patients in daily doses of 1,200 to 3,000 mg was associated with a significant reduction of the platelet count. Thrombocytopenia without any concomitant bleeding abnormalities occurred in 10 of the patients. Platelet counts returned to baseline levels after withdrawal of the drug.
Key concepts: Concomitant, Medicine, Platelet, Valproic Acid, Internal medicine, Anesthesia, Sodium, Drug